Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures
Flanagan, Eoin P. , McKeon, Andrew , Watson, Robert E. , Klein, Christopher J. , Lowe, Val J. , Ahlskog, J. Eric , Shin, Cheolsu, Laughlin, Ruple S. , Pittock, Sean J. , Kotsenas, Amy L. , Boes, Christopher J. , Crum, Brian A. , Pittock, S J , Britton, Jeffrey W. , Boeve, Bradley F. , Flanagan, E P , Klein, Christopher J , McKeon, Andrew

Neurology Neuroimmunology & Neuroinflammation | October 2, 2015 | Volume: 2 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000000161 | PMID 26468474 Get It

Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease
Tian, Na , Leffler, Daniel A. , Kelly, Ciarán P. , Hansen, Joshua, Marietta, Eric, Schuppan, Detlef, Marietta, Eric V., Murray, Joseph A. , Helmerhorst, Eva J.

American Journal of Physiology-Gastrointestinal and Liver Physiology | October 2, 2015 | Volume: 309 | Issue: 11 | Pages: G910-G917

10.1152/ajpgi.00157.2015 | PMID 26505973 Get It

Celiac disease (CD) is an inflammatory disorder triggered by ingested gluten, causing immune-mediated damage to the small-intestinal mucosa. Gluten proteins are strikingly similar in amino acid composition and sequence to proline-rich proteins (PRPs) in human saliva. On the basis of this feature and their shared destination in the gastrointestinal tract, we hypothesized that salivary PRPs may modulate gluten-mediated immune responses in CD. Parotid salivary secretions were collected from CD patients, refractory CD patients, non-CD patients with functional gastrointestinal complaints, and healthy controls. Structural similarities of PRPs with gluten were probed with anti-gliadin antibodies. Immune responses to PRPs were investigated toward CD patient-derived peripheral blood mononuclear cells and in a humanized transgenic HLA-DQ2/DQ8 mouse model for CD. Anti-gliadin antibodies weakly cross-reacted with the abundant salivary amylase but not with PRPs. Likewise, the R5 antibody, recognizing potential antigenic gluten epitopes, showed negligible reactivity to salivary proteins from all groups. Inflammatory responses in peripheral blood mononuclear cells were provoked by gliadins whereas responses to PRPs were similar to control levels, and PRPs did not compete with gliadins in immune stimulation. In vivo, PRP peptides were well tolerated and nonimmunogenic in the transgenic HLA-DQ2/DQ8 mouse model. Collectively, although structurally similar to dietary gluten, salivary PRPs were nonimmunogenic in CD patients and in a transgenic HLA-DQ2/DQ8 mouse model for CD. It is possible that salivary PRPs play a role in tolerance induction to gluten early in life. Deciphering the structural basis for the lack of immunogenicity of salivary PRPs may further our understanding of the toxicity of gluten.
First Steps toward Harmonization of LC-MS/MS Thyroglobulin Assays
Netzel, Brian C., Grant, Russell P. , Hoofnagle, Andrew N. , Rockwood, Alan L. , Shuford, Christopher M. , Grebe, Stefan K., Grebe, Stefan K G

Clinical Chemistry | October 1, 2015 | Volume: 62 | Issue: 1 | Pages: 297-299

10.1373/clinchem.2015.245266 | PMID 26430076 Get It

Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration
Bergen, H. Robert, Dasari, Surendra , Dispenzieri, Angela , Mills, John R. , Ramı́rez-Alvarado, Marina , Tschumper, Renee C. , Jelinek, Diane F., Barnidge, David R. , Murray, David , Dispenzieri, Angela , Ramirez-Alvarado, Marina

Clinical Chemistry | October 1, 2015 | Volume: 62 | Issue: 1 | Pages: 243-251

10.1373/clinchem.2015.242651 | PMID 26430073 Get It

Abstract BACKGROUND Analytically sensitive techniques for measuring minimal residual disease (MRD) in multiple myeloma (MM) currently require invasive and costly bone marrow aspiration. These methods include immunohistochemistry (IHC), flow cytometry, quantitative PCR, and next-generation sequencing. An ideal MM MRD test would be a serum-based test sensitive enough to detect low concentrations of Ig secreted from multifocal lesions. METHODS Patient serum with abundant M-protein before treatment was separated on a 1-dimensional SDS-PAGE gel, and the Ig light-chain (LC) band was excised, trypsin digested, and analyzed on a Q Exactive mass spectrometer by LC-MS/MS. We used the peptide's abundance and sequence to identify tryptic peptides that mapped to complementary determining regions of Ig LCs. The clonotypic target tryptic peptides were used to monitor MRD in subsequent serum samples with prior affinity enrichment. RESULTS Sixty-two patients were tested, 20 with no detectable disease by IHC and 42 with no detectable disease by 6-color flow cytometry. A target peptide that could be monitored was identified in 57 patients (91%). Of these 57, detectable disease by LC-MS/MS was found in 52 (91%). CONCLUSIONS The ability to use LC-MS/MS to measure disease in patients who are negative by bone marrow–based methodologies indicates that a serum-based approach has more analytical sensitivity and may be useful for measuring deeper responses to MM treatment. The method requires no bone marrow aspiration.
Using matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine
Barnidge, David R. , Krick, Thomas P., Griffin, Timothy J. , Murray, David , Murray, David L., Griffin, Timothy J

Rapid Communications in Mass Spectrometry | October 1, 2015 | Volume: 29 | Issue: 21 | Pages: 2057-2060

10.1002/rcm.7314 | PMID 26443406 Get It

Rationale Use of matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI‐TOFMS) to monitor serum and urine samples for endogenous monoclonal immunoglobulins. MALDI‐TOFMS is faster, fully automatable, and provides superior specificity compared to protein gel electrophoresis (PEL). Methods Samples were enriched for immunoglobulins in 5 min using Melon Gel™ followed by reduction with dithiothreitol for 15 min to separate immunoglobulin light chains and heavy chains. Samples were then desalted using C4 ZipTips, mixed with sinapinic acid matrix, and analyzed on a Bruker Biflex III MALDI‐TOF mass spectrometer. Results Monoclonal immunoglobulin light chains were identified in serum and urine samples from patients with a known monoclonal gammopathy using MALDI‐TOFMS with minimal sample preparation. Conclusions MALDI‐TOFMS can identify a monoclonal immunoglobulin in serum and urine samples. The molecular mass of the monoclonal immunoglobulin light chain is obtained providing unprecedented specificity compared to PEL. In addition, the methodology can be automated, making it a practical alternative to PEL. Copyright © 2015 John Wiley & Sons, Ltd.
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Success and safety
Minha, Sa’ar , Waksman, Ron , Satler, Lowell P., Torguson, Rebecca, Alli, Oluseun , Rihal, Charanjit S. , Mack, Michael J. , Svensson, Lars G. , Rajeswaran, Jeevanantham , Tuzcu, E. Murat , Thourani, Vinod H. , Makkar, Raj , Ehrlinger, John, Lowry, Ashley M. , Suri, Rakesh M. , Greason, Kevin L. , Leon, Martin B. , Holmes, David R. , Pichard, Augusto D., Rihal, Charanjit S. , Blackstone, Eugene H.

Catheterization and Cardiovascular Interventions | October 1, 2015 | Volume: 87 | Issue: 1 | Pages: 165-175

10.1002/ccd.26121 | PMID 26425793 Get It

ObjectivesTo identify number of cases needed to maximize device success and minimize adverse events after transfemoral transcatheter aortic valve replacement (TF‐TAVR), and determine if adverse events were linked to the technical performance learning curve.BackgroundTF‐TAVR is a complex procedure with an incompletely characterized learning curve for clinical outcomes.MethodsFrom 4/2007–2/2012, 1521 patients underwent TF‐TAVR in the PARTNER‐I trial. Outcomes learning curves were defined as number of cases needed to reach a plateau for device success, adverse events, and post‐procedure length of stay. Institutional variation was accounted for by mixed‐model non‐linear techniques, which were also used to identify contribution of the procedure time learning curve to 30‐day major adverse events and length of stay.ResultsEighty percent device success was achieved after 22 cases; major vascular complications fell below 5% after 70 cases and major bleeding below 10% after 25 cases. It took an average of 28 cases to achieve a consistent low risk of 30‐day major adverse events, but institutions entering in the middle of the trial achieved it after about 26. The most significant correlate of 30‐day major adverse events and post‐procedure length of stay was procedure time (P < 0.0001). However, this association was related to patient and unmeasured variables, not the procedure time learning curve (P = 0.6).ConclusionsBy end of trial, a consistent low risk of adverse events was achieved after ∼26 cases. However, these improved results were due to change in patient risk profile; outcomes were not linked to the technical performance learning curve. © 2015 Wiley Periodicals, Inc.
Transcatheter aortic valve replacement for native aortic valve regurgitation as a bridge to liver transplantation
Cabasa, Alduz S., Eleid, Mackram F. , Suri, Rakesh M.

Catheterization and Cardiovascular Interventions | October 1, 2015 | Volume: 88 | Issue: 4 | Pages: 665-670

10.1002/ccd.26264 | PMID 26425919 Get It

Coexistence of end‐stage liver disease (ESLD) and severe valvular heart disease conveyed substantial risk for patients, oftentimes leading to exclusion from liver transplantation candidacy due to inability to safely offer cardiac surgery prior to transplantation. Several approaches have been described, including performing transplantation and valve surgery concurrently, or in sequence. Both options, however, have associated complications: catastrophic repercussion of peri‐operative coagulopathy and organ dysfunction post‐transplantation, respectively. The introduction of transcatheter procedures offered a safer alternative for high‐risk patients; however, its recognized indications remained limited. A novel approach to this surgical dilemma by performing transcatheter aortic valve replacement (TAVR) for severe native aortic valve regurgitation in a patient on the liver transplant list has been presented. The procedure proved to be an effective management for the aortic valve insufficiency, improving our patient's hemodynamics in preparation for the subsequent orthotopic liver transplantation (OLT). © 2015 Wiley Periodicals, Inc.
Catatonia is a systemic medical syndrome
Fink, Max , Rummans, Teri, Shorter, Edward , Fricchione, Gregory L.

Acta Psychiatrica Scandinavica | October 1, 2015 | Volume: 133 | Issue: 3 | Pages: 250-251

10.1111/acps.12510 | PMID 26426740 Get It

P14.04: Persistent notochord in a fetus with COL2A1 mutation: a case report
Codsi, Elisabeth , Borowski, Kristi, Faksh, Arij , Trinidad, Mari Charisse, Rose, Carl H., White, Wendy , Davies, Nathan A. , Brost, Brian

Ultrasound in Obstetrics & Gynecology | October 1, 2015 | Volume: 46 | Issue: S1 | Pages: 165-165

10.1002/uog.15447 Get It

P13.04: Accuracy and learning curves of crown–rump length measurements performed by certified nurse midwives
Codsi, Elisabeth, Brodick, E.M., Trinidad, Mari Charisse, Faksh, Arij , Nitsche, Joshua F. , Brost, Brian

Ultrasound in Obstetrics & Gynecology | October 1, 2015 | Volume: 46 | Issue: S1 | Pages: 162-162

10.1002/uog.15438 Get It